ARCHIVES

Includes January Business & Regulatory Report (8-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 05 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Changes Deadlines For Two RFAS

July 18, 1997

Nexavar Phase III Trial Fails To Meet Primary Endpoint

June 29, 2012

FDA Approves Silicone Gel Breast Implants, Requires 10 Years Of Patient Follow-Up

November 24, 2006

Trials Approved by NCI CTEP For the Month of December

December 30, 2011

HHS lawyer tells of pressure to allow former NCI Director Richard Klausner to receive $40,000 prize.

May 21, 2004

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

November 29, 2002